Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BST/30J stock hub

BST/30J has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BST/30Jis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.1B

Stuttgart Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BST/30J

In the news

Latest news · BST/30J

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-14.3

P25 n/aP50 n/aP75 n/a

ROIC-11.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BST/30J market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

146

Groups with data

Currency

USD

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	145
Employees Change	14%
Employees Change Percent	10.69
Enterprise value	EUR 1.3B
Exchange	Stuttgart Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 2.1B
Price	EUR 23.95
Price currency	EUR
Rev Per Employee	1,347,425.32x
Sic	2836
Symbol	bst/30J
Website	https://www.ideayabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.75%
EV Earnings	-10.8x
EV/FCF	-17.2x
EV/Sales	6.85x
FCF yield	-3.61%
P/B ratio	2.6x
P/S ratio	10.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-81.44%
EBITDA Margin	-80.21%
Gross margin	-50.73%
Gross Profit	EUR -99.1M
Net Income	EUR -121.5M
Pretax Margin	-62.17%
Profit Margin	-62.17%
Profit Per Employee	EUR -837,746
ROA	-10.76
Roa5y	-13.51
ROCE	-19
ROE	-14.28
Roe5y	-20.96
ROIC	-11.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.2%
Revenue Growth	3,118.14x
Revenue Growth3 Y	68.07x
Revenue Growth5 Y	53.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.21
Assets	EUR 893.6M
Cash	EUR 582.1M
Current Assets	EUR 590.3M
Current Liabilities	EUR 55M
Debt	EUR 24.8M
Debt Equity	EUR 0.03
Debt FCF	EUR -0.33
Equity	EUR 812.9M
Liabilities	EUR 80.7M
Long Term Assets	EUR 303.3M
Long Term Liabilities	EUR 25.8M
Net Cash	EUR 819M
Net Cash By Market Cap	EUR 38.74
Net Cash Growth	-7.89%
Net Debt Equity	EUR -1.01
Tangible Book Value	EUR 812.9M
Tangible Book Value Per Share	EUR 9.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.74
Net Working Capital	EUR -34.3M
Quick ratio	10.45
Working Capital	EUR 547.5M
Working Capital Turnover	EUR 0.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.2%
50-day SMA	27.23
All Time High	43
All Time High Change	-44.3%
All Time High Date	2024-02-14
All Time Low	18.3
All Time Low Change	30.87%
All Time Low Date	2025-06-26
ATR	1.05
Ch YTD	-16.26
High	24.2
High52	32.6
High52 Date	2026-01-08
High52ch	-26.53%
Low	23.78
Low52	18.3
Low52 Date	2025-06-26
Low52ch	30.87%
Ma50ch	-12.05%
RSI	36.08
RSI Monthly	36.54
RSI Weekly	43.5
Sharpe ratio	-0.41x
Sortino ratio	-0.46
Total Return	-4.21%
Tr YTD	-16.26
Tr1m	-9.42%
Tr1w	-2.64%
Tr3m	-11.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -159.1M
Operating margin	-81.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	87,007,943%
Shares Insiders	0.97%
Shares Institutions	110.72%
Shares Qo Q	0.13%
Shares Yo Y	4.21%
Short Ratio	8.88

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -120M
Average Volume	58.3x
Bv Per Share	9.25
CAPEX	EUR -1.7M
Ch1m	-9.42
Ch1w	-2.64
Ch1y	-4.2
Ch3m	-11.95
Ch6m	-7.88
Change	0%
Change From Open	0.42
Close	23.95
Days Gap	-0.42
Depreciation Amortization	2,364,118.1
Earnings Date	2026-08-05
EBIT	EUR -159.1M
EBITDA	EUR -156.7M
EPS	EUR -1.37
F Score	3
FCF	EUR -76.3M
FCF EV Yield	-5.81x
Financing CF	4,177,784
Fiscal Year End	December
Founded	2,015
Investing CF	94,631,970
Is Primary Listing	0
Last Report Date	2026-03-31
Ma20	25.93
Ma20ch	-7.65%
Net CF	24,286,135
Next Earnings Date	2026-08-05
Open	23.85
Position In Range	40.48
Ppne	26,496,268.6
Price Date	2026-05-08
Ptbv Ratio	2.6
Relative Volume	285.05x
Revenue	195,376,671x
SBC By Revenue	22.38x
Share Based Comp	43,724,062
Tr6m	-7.88%
Z Score	14.59

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BST/30J pay a dividend?

Capital-return profile for this ticker.

Performance

BST/30J stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BST/30J?

Insider, institutional, and short-interest positioning.

Institutional ownership

+110.7%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BST/30J momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.1

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BST/30J

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bst/30J stock rating?

bst/30J is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bst/30J analysis?

The full report lives at /stocks/bst/30J/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bst/30J?

The latest report frames bst/30J around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bst/30J page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.